Bill Commons

MA S 871

in committee

An Act ensuring equal access to medical treatments essential for people with a developmental disability, intellectual disability, or autism

Massachusetts · 2025-2026 Regular Session (194th General Court) · upper

Description

By Mr. Keenan, a petition (accompanied by bill, Senate, No. 871) of John F. Keenan, James B. Eldridge, James K. Hawkins, Michael O. Moore and other members of the General Court for legislation to require MassHealth to cover medical treatments essential for people with a developmental disability, intellectual disability, or autism. Health Care Financing.

Introduced
—
Status date
—
Latest action
2026-01-29 — Accompanied a study order, see S2931
Bill type
bill
Last updated
—

Sponsors

  • John F. Keenanprimary
  • James B. Eldridgecosponsor
  • James K. Hawkinscosponsor
  • Michael O. Moorecosponsor
  • Manny Cruzcosponsor
  • Michael D. Bradycosponsor
  • Patrick M. O'Connorcosponsor
  • Mike Connollycosponsor
  • Paul R. Feeneycosponsor
  • Pavel M. Payanocosponsor

Committees

Not provided by source.

Action timeline

  1. 2025-02-27

    Referred to the committee on Health Care Financing

    referral-committee

  2. 2025-02-27

    House concurred

  3. 2025-06-24

    Hearing scheduled for 07/01/2025 from 10:00 AM-12:30 PM in Gardner Auditorium

  4. 2026-01-29

    Accompanied a study order, see S2931

Versions

Documents

Votes

Not provided by source.

Related bills

Official source

https://malegislature.gov/Bills/194/S871

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:22:56.590024Z

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=MA&identifier=S 871. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.
  • Some documents have no extracted text yet, so version comparison may be limited.

See the methodology page for data sources and limitations.